3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Multiple Myeloma
420
Lymphoma, Large B-Cell, Diffuse
93
Leukemia, Lymphocytic, Chronic, B-Cell
88
Lymphoma, Follicular
79
Recurrence
68
Lymphoma
60
Neoplasms, Plasma Cell
57
Lymphoma, Mantle-Cell
56
Lymphoma, B-Cell, Marginal Zone
47
Lymphoma, Non-Hodgkin
46
Leukemia, Myeloid, Acute
34
Leukemia
32
Lymphoma, B-Cell
24
Neoplasms
23
Myelodysplastic Syndromes
23
Waldenstrom Macroglobulinemia
18
Hodgkin Disease
18
Smoldering Multiple Myeloma
17
Lymphoma, T-Cell, Peripheral
16
Burkitt Lymphoma
14
Hematologic Diseases
13
Lymphoma, T-Cell, Cutaneous
12
Lymphoma, T-Cell
12
Prostatic Neoplasms
11
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Sezary Syndrome
10
Mycosis Fungoides
10
Lymphoma, Large-Cell, Anaplastic
9
Leukemia, Myelomonocytic, Chronic
9
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
8
Interventions
Acupuncture Therapy
10
Exercise
7
Cryotherapy
6
Paclitaxel
5
Glutamine
5
Surveys and Questionnaires
3
Duloxetine Hydrochloride
3
Dexamethasone
3
Bortezomib
3
Acetylcysteine
3
Thioctic Acid
2
Tablets
2
Sodium Chloride
2
Saline Solution
2
Physical Therapy Modalities
2
Low-Level Light Therapy
2
Fish Oils
2
Fatty Acids, Omega-3
2
ziconotide
1
sagopilone
1
pembrolizumab
1
nicotinamide-beta-riboside
1
nabilone
1
glutamic acid diethyl ester
1
enfortumab vedotin
1
allantoicase
1
Yoga
1
XELOX
1
Vitamin D
1
Vitamin B Complex
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Peripheral Nervous System Diseases
×
Lenalidomide
×
Clear all
NCT07025005
2025-11-04
VRd MM Fibrate
Tanta University
Phase 4
Recruiting
44 enrolled